Pasithea Therapeutics (KTTA) Earnings Date, Estimates & Call Transcripts

$7.24
0.00 (0.00%)
(As of 04/26/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

KTTA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KTTA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

KTTA Earnings Date and Information

Pasithea Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, June 27th, 2024 based off prior year's report dates.

Pasithea Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
6/27/2024
Estimated)
------- 
11/13/2023Q3 2023-($2.80)($2.80)($0.14)--

Pasithea Therapeutics Earnings - Frequently Asked Questions

When is Pasithea Therapeutics's earnings date?

Pasithea Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, June 27th, 2024 based off last year's report dates. Learn more on KTTA's earnings history.

How much revenue does Pasithea Therapeutics generate each year?

Pasithea Therapeutics (NASDAQ:KTTA) has a recorded annual revenue of $20,000.00.

How much profit does Pasithea Therapeutics generate each year?

Pasithea Therapeutics (NASDAQ:KTTA) has a recorded net income of -$15.96 million. KTTA has generated $0.00 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:KTTA) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners